GOLIMUMAB treats autoimmune conditions, such as arthritis and ulcerative colitis. It works by slowing down an overactive immune system. It belongs to a group of medications called TNF inhibitors. It is a monoclonal antibody. With the Patient Assistance Program from PAN Foundation, contact the program to see how they can financially help you out.
